Adeno-Associated Virus (AAV) Vectors in the CNS

Publisher： Bentham Science Publishers

E-ISSN： 1875-5631|5|3|333-338

ISSN： 1566-5232

Source： Current Gene Therapy, Vol.5, Iss.3, 2005-06, pp. : 333-338

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Adeno-Associated Virus (AAV) Vectors in the CNS

By  

Current Gene Therapy, Vol. 11, Iss. 3, 2011-06 ,pp. : 181-188

Bentham Science Publishers

Access to resources Recommend Favorite

Generation of Targeted Adeno-Associated Virus (AAV) Vectors for Human Gene Therapy

By  

Current Pharmaceutical Design, Vol. 21, Iss. 22, 2015-01 ,pp. : 3248-3256

Bentham Science Publishers

Access to resources Recommend Favorite

Developing Immunologically Inert Adeno-Associated Virus (AAV) Vectors for Gene Therapy: Possibilities and Limitations

By  

Current Pharmaceutical Biotechnology, Vol. 14, Iss. 12, 2013-01 ,pp. : 1072-1082

Bentham Science Publishers

Access to resources Recommend Favorite

From Virus Evolution to Vector Revolution: Use of Naturally Occurring Serotypes of Adeno-associated Virus (AAV) as Novel Vectors for Human Gene Therapy

By  

Current Gene Therapy, Vol. 3, Iss. 4, 2003-01 ,pp. : 281-304

Bentham Science Publishers

Access to resources Recommend Favorite

Immune Responses to Adeno-Associated Virus Vectors

By  

Current Gene Therapy, Vol. 5, Iss. 3, 2005-01 ,pp. : 323-331

Bentham Science Publishers

Access to resources Recommend Favorite